⌘K

Home/Filings/4/0001493152-22-026509

4//SEC Filing

Busch Jeffrey 4

Accession 0001493152-22-026509

CIK 0001362703other

View on SEC.gov Company Profile

Filed

Sep 20, 8:00 PM ET

Accepted

Sep 21, 6:27 PM ET

Size

5.6 KB

Accession

0001493152-22-026509

Insider Transaction Report

Form 4

Period: 2022-09-16

THERALINK TECHNOLOGIES, INC.THER

Director

Transactions

Award
Stock Option (right to buy)
2022-09-16+469,738,712→ 469,738,712 total
Exercise: $0.00Exp: 2032-09-16→ Common Stock (469,738,712 underlying)

Footnotes (1)

[F1]375,790,967 of the stock options will become exercisable upon the filing by the corporation of an S-8 registration statement covering its 2022 Equity Incentive Plan. The remaining 93,947,745 stock options will vest on May 1, 2023.

Documents

1 file

4
ownership.xmlPrimary

Issuer

THERALINK TECHNOLOGIES, INC.

CIK 0001362703

Entity typeother

Related Parties

1

filerCIK 0001620772

Filing Metadata

Form type: 4
Filed: Sep 20, 8:00 PM ET
Accepted: Sep 21, 6:27 PM ET
Size: 5.6 KB

View on SEC.gov